 |
Corporate News
30-Nov-22
|
|
|
|
|
|
|
|
|
|
|
|
J B Chemical receives USFDA approval for Venlafaxine Extended Release Tablets
|
|
|
|
|
|
|
|
J B Chemicals & Pharmaceuticals has received ANDA approval from the USFDA for Venlafaxine Extended Release Tablets 37.5mg, 75mg, 150mg and 225mg. This product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an advanced and precision-controlled release mechanism. The generic product approval is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, 75 mg, 150 mg, and
225 mg, of Osmotica Pharmaceutical U.S. LLC.
As per IQVIA Health MAT Oct 2022 data, Venlafaxine Extended-Release tablets recorded annualized sales of approximately $ 48 million in the US.
|
|
|
|
Previous News |
J B Chemicals & Pharmaceuticals consolidated net profit rises 25.89% in the December 2023 quarter
(
Results
-
Announcements
06-Feb-24
17:14
)
|
|
|
J B Chemicals & Pharmaceuticals fixes record date for interim dividend
(
Market Beat
-
Reports
06-Feb-24
16:48
)
|
|
|
J B Chemicals & Pharmaceuticals appoints director
(
Corporate News
-
07-Nov-23
18:13
)
|
|
|
J B Chemicals & Pharmaceuticals to hold AGM
(
Corporate News
-
01-Jul-23
18:36
)
|
|
|
J B Chemicals & Pharmaceuticals allots 78,440 equity shares under ESOS
(
Corporate News
-
07-Nov-23
18:14
)
|
|
|
J B Chemicals & Pharmaceuticals to hold board meeting
(
Corporate News
-
08-Feb-22
12:26
)
|
|
|
J B Chemicals & Pharmaceuticals standalone net profit rises 25.78% in the June 2016 quarter
(
Results
-
Announcements
26-Aug-16
14:36
)
|
|
|
J B Chemicals & Pharmaceuticals receives EIR for manufacturing facility at Panoli, Gujarat
(
Corporate News
-
11-Feb-20
12:44
)
|
|
|
J B Chemicals & Pharmaceuticals to acquire Razel franchise for India and Nepal region
(
Corporate News
-
14-Dec-22
19:21
)
|
|
|
J B Chemicals & Pharmaceuticals to acquire trademarks portfolio of Unique Pharma
(
Corporate News
-
04-Feb-20
17:14
)
|
|
|
J B Chemicals & Pharamaceuticals reports standalone net profit of Rs 24.17 crore in the December 2014 quarter
(
Results
-
Announcements
05-Feb-15
10:10
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|